Overview

The Acute Effects of the Angiotensin-converting Enzyme Inhibitor Enalaprilat on Flow Distribution

Status:
Completed
Trial end date:
2010-01-01
Target enrollment:
Participant gender:
Summary
The primary objective of this study is to study the acute effects of angiotensin-converting enzyme inhibitor (ACEI) on systemic, pulmonary and cerebral blood flow in post bidirectional cavopulmonary connection (BCPC) patients.
Phase:
Phase 3
Details
Lead Sponsor:
The Hospital for Sick Children
Treatments:
Angiotensin-Converting Enzyme Inhibitors
Enalapril
Enalaprilat
Enzyme Inhibitors